Physician profile
Bilal Lateef
NPI 1528404670
$4,212.02
in general payments reported to CMS, 2019-2025
16 companies · $906 in 2025
The $906 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $27.22 · 2021: $74.18 · 2022: $245 · 2023: $316 · 2024: $1,511 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326 · Travel and Lodging: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.66 |
| Travel and Lodging | $407.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,632.68 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Medtronic USA, INC. | $1,000.98 | 2019-2020 | |
| Boston Scientific Corporation | $610.61 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $215.58 | 2024 | Senza |
| Averitas Pharma INC. | $154.11 | 2024-2025 | Qutenza |
| Globus Medical, INC. | $150.41 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $133.61 | 2019-2024 | Belbuca |
| Grt US Holding, INC. | $57.51 | 2022 | |
| Abbvie INC. | $55.28 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $43.64 | 2025 | |
| Tersera Therapeutics LLC | $40.66 | 2025 | Prialt |
| Si-Bone, INC. | $38.77 | 2025 | |
| Vertos Medical, INC. | $27.65 | 2023 | Mild Device Kit |
| Abbott Laboratories | $21.98 | 2025 | Eterna |
| Eagle Pharmaceuticals, INC. | $14.89 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Lateef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.